Ann: Mesoblast Maintains Momentum with FDA, page-60

  1. 1,250 Posts.
    lightbulb Created with Sketch. 147
    assuming the next quarterly is the goods in terms of revenue (signs that they are going to be on track for being self sustainable cash flow wise: Ryoncil sales): they know that they can quietly buy back for a couple of weeks: doable given the ADV we have seen but would nonetheless be positive for the share price until then (assuming even half of them don't want to be exposed by the time the report drops).
    Last edited by AnotherOneWon: Thursday, 13:43
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.83
Change
-0.035(1.88%)
Mkt cap ! $2.331B
Open High Low Value Volume
$1.88 $1.94 $1.82 $11.55M 6.216M

Buyers (Bids)

No. Vol. Price($)
2 40245 $1.83
 

Sellers (Offers)

Price($) Vol. No.
$1.84 25000 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.